Next Article in Journal
Circulating Asprosin Declines During 24 Months of Growth Hormone Replacement and Is Associated with IGF-1 and Metabolic Remodeling in Adults with Growth Hormone Deficiency
Previous Article in Journal
Environmental Pollution, Biomarkers, and Dementia: An Evidence Review
Previous Article in Special Issue
Prevalence of Mismatch Repair Deficiency and Its Association with Histopathological Parameters in Endometrial Cancer: A Prospective Cohort Study
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

SIRT1 Promotes Breast Cancer Stem Cell-Associated Properties and Represents a Potential Therapeutic Target

1
Department of Pathology & Immunology, Baylor College of Medicine, One Baylor Plaza, Houston, TX 77030, USA
2
Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA
3
Texas Therapeutics Institute, Brown Foundation Institute of Molecular Medicine, McGovern Medical School, University of Texas Health Science Center at Houston, 1825 Pressler Street, Houston, TX 77030, USA
4
Center of Molecular Imaging, Brown Foundation Institute of Molecular Medicine, McGovern Medical School, University of Texas Health Science Center at Houston, 1825 Pressler Street, Houston, TX 77030, USA
*
Author to whom correspondence should be addressed.
Int. J. Mol. Sci. 2026, 27(18), 8226; https://doi.org/10.3390/ijms27188226
Submission received: 31 July 2026 / Revised: 1 September 2026 / Accepted: 8 September 2026 / Published: 15 September 2026

Abstract

Breast cancer stem cells (BCSCs) drive tumor progression, metastasis, and therapeutic resistance. Sirtuin 1 (SIRT1) has been implicated in stem cell regulation, but its context-dependent role in BCSC maintenance and the underlying molecular mechanisms remain poorly defined. SIRT1 expression was evaluated in human breast cancer specimens. Pharmacologic and genetic SIRT1 inhibition was assessed in breast cancer cell lines and orthotopic xenograft models to determine effects on stemness, epithelial–mesenchymal transition (EMT), metastasis, and chemoresistance, with emphasis on Wnt/β catenin signaling. SIRT1 was overexpressed in breast cancer and correlated with higher tumor grades. SIRT1 inhibition reduced BCSC markers (CD44, ALDH1), stemness genes (NANOG, SOX-2), mammosphere formation, EMT, and invasion. In vivo, SIRT1 inhibition suppressed tumor growth, blocked lymphatic metastasis, and delayed cisplatin resistance. Mechanistically, these effects were mediated by downregulation of Disheveled 3 (DVL3) and attenuation of Wnt/β catenin signaling. SIRT1 is associated with the maintenance of BCSC-related properties, EMT, and activation of the Wnt/β-catenin pathway in breast cancer. Targeting SIRT1 may represent a potential therapeutic strategy to suppress tumor progression and improve treatment response.
Keywords: breast cancer; cancer stem cell (CSC); breast cancer stem cell (BCSC); epithelial–mesenchymal transition (EMT); SIRT1; SIRT1 inhibitor; TGF-β; Wnt/β-catenin pathway; DVL breast cancer; cancer stem cell (CSC); breast cancer stem cell (BCSC); epithelial–mesenchymal transition (EMT); SIRT1; SIRT1 inhibitor; TGF-β; Wnt/β-catenin pathway; DVL

Share and Cite

MDPI and ACS Style

Ding, J.; Guan, B.; Fan, X.; Zhang, N.; Sevick, E.; Zhang, S. SIRT1 Promotes Breast Cancer Stem Cell-Associated Properties and Represents a Potential Therapeutic Target. Int. J. Mol. Sci. 2026, 27, 8226. https://doi.org/10.3390/ijms27188226

AMA Style

Ding J, Guan B, Fan X, Zhang N, Sevick E, Zhang S. SIRT1 Promotes Breast Cancer Stem Cell-Associated Properties and Represents a Potential Therapeutic Target. International Journal of Molecular Sciences. 2026; 27(18):8226. https://doi.org/10.3390/ijms27188226

Chicago/Turabian Style

Ding, Jianmin, Baoxiang Guan, Xuejun Fan, Ningyan Zhang, Eva Sevick, and Songlin Zhang. 2026. "SIRT1 Promotes Breast Cancer Stem Cell-Associated Properties and Represents a Potential Therapeutic Target" International Journal of Molecular Sciences 27, no. 18: 8226. https://doi.org/10.3390/ijms27188226

APA Style

Ding, J., Guan, B., Fan, X., Zhang, N., Sevick, E., & Zhang, S. (2026). SIRT1 Promotes Breast Cancer Stem Cell-Associated Properties and Represents a Potential Therapeutic Target. International Journal of Molecular Sciences, 27(18), 8226. https://doi.org/10.3390/ijms27188226

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop